手法复位联合药物治疗良性阵发性位置性眩晕的疗效分析

Clinical efficacy of CRP combined with betahistine in the treatment of benign paroxysmal positional vertigo(BPPV)

目的探讨手法复位解脱管石联合倍他司汀药物治疗良性阵发性位置性眩晕(BPPV)的临床疗效。方法将80例确诊为BPPV的患者随机分为治疗组和对照组,每组40例,治疗组给予手法复位联合倍他司汀药物治疗,对照组单纯给予手法复位治疗。统计治疗疗效,记录1个疗程(2周)中的第1、7及14天的缓解例数,并随访至治愈后1个月。结果治疗组的首次有效率为70.83%,对照组为68.75%,治疗组明显高于对照组(χ~2=0.04,P<0.05)。治疗组在1个疗程之内的总有效率也明显优于对照组(χ2=0.94,P<0.05),1个月后随访的复发率治疗组也较对照组明显少。结论手法复位联合倍他司汀对治疗良性阵发性位置性眩晕有良好的效果。

Objective To explore the clinical efficacy of CRP combined with betahistine in the treatment of benign paroxysmal positional vertigo （BPPV） . Methods Eighty patients diagnosed as BPPV were randomly divided into treat- ment group and compare group, 40 cases in each group. The treatment group was given CRP combined with betahistine drug therapy. The control group was treated by CRP. The curative effect was recorded. The number of remission on the 1 st, 7th and 14th day in a course of treatment （2 weeks） was recorded and followed up to 1 month after cure. Results The first effective rate was 70.83% in the treatment group and 68.75% in the control group, the treatment group was significantly higher than the control group （χ2=0.04, P〈0.05） . The total effec- tive rate in the treatment group was also significantly better than that in the control group （χ2=0.94, P〈0.05） . The recurrence rate of the treatment group was also less than that of the control group. Conclusion CRP combined with betahistine has a good effect on the treatment of benign paroxysmal positional vertigo （BPPV） .